Lazard Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Lazard Asset Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-616	Closed	-$59K	–	1797
2020 Q2	$59K	Buy	616 +238	+63%	+$22.1K	﹤0.01%	1187
2020 Q1	$31K	Buy	+378	New	+$36.9K	﹤0.01%	1345
2018 Q1	–	Sell	-110	Closed	-$10K	–	1152
2017 Q4	$10K	Buy	+110	New	+$9.15K	﹤0.01%	992
2016 Q1	–	Sell	-6,700	Closed	-$303K	–	1136
2015 Q4	$303K	Buy	6,700 +910	+16%	+$38.2K	﹤0.01%	766
2015 Q3	$224K	Buy	5,790 +700	+14%	+$28K	﹤0.01%	768
2015 Q2	$184K	Buy	5,090 +490	+11%	+$15.5K	﹤0.01%	849
2015 Q1	$132K	Buy	+4,600	New	+$128K	﹤0.01%	890

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Lazard Asset Management's PRAH Position: Q3 2020 in Review

Lazard Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2020, closing a stake of 616 shares — an estimated $59K sold.

Lazard Asset Management first reported a position in PRAH in Q1 2015 and held it in 7 quarters. The position peaked at $303K in Q4 2015. 281 funds tracked by Wall St. Rank hold PRAH as of Q3 2020.

Lazard Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2020 after selling out during the quarter.
Lazard Asset Management sold 616 PRA Health Sciences, Inc. shares in Q3 2020, an estimated $59K.
Lazard Asset Management first reported a position in PRA Health Sciences, Inc. in Q1 2015 and held it in 7 quarters.
Lazard Asset Management's PRA Health Sciences, Inc. position peaked at $303K in Q4 2015.
281 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2020.

Based on Lazard Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.